AXSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Axsome Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$155.81−1.33 (-0.85%)
Close on Oct 19, 2026
- Market cap
- $8.07B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Axsome Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 15, 2026 | Jul 15, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2026 | Jun 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 3, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 4, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 24, 2026 | Apr 24, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2026 | Apr 1, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 17, 2026 | Feb 17, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 31, 2025 | Dec 31, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 19, 2025 | Aug 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 10, 2025 | Jun 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2025 | Jun 9, 2025 | SEC EDGAR |
| Current report | 8-K | May 27, 2025 | May 27, 2025 | SEC EDGAR |
| Current report | 8-K | May 8, 2025 | May 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 5, 2025 | SEC EDGAR |
| Current report | 8-K | May 5, 2025 | May 5, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 25, 2025 | Apr 25, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2025 | Apr 1, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 25, 2025 | Mar 25, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 5, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2025 | Mar 3, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 18, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2025 | Feb 18, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 10, 2025 | Feb 10, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2025 | Jan 31, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 30, 2024 | Dec 30, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 26, 2024 | Nov 26, 2024 | SEC EDGAR |